| Precision Therapeutics is a CLIA-certified clinical laboratory |
Hepatobiliary Cancer
Hepatobiliary cancer occurs when abnormal growths develop in or on the liver, bile ducts and biliary tract (the tubes that carry bile from the liver or gallbladder to the small intestine). The most common of these cancers in the United States is gall bladder cancer. In the United States, more the 9,500 new biliary cancer cases were estimated for 2009.
Hepatobiliary Cancer Treatment Options
Surgery is often used to treat hepatobiliary cancers. Chemotherapy, targeted therapies and radiation may also be used. These treatments can be used alone but are often used in combination. Radiation therapy and chemotherapy are also used as palliative treatment for the hepatobiliary cancer. With liver cancer, sometimes a liver transplant is required. Those waiting for a transplant sometimes receive radiofrequency ablation or percutaneous ethanol injection.
Hepatobiliary Cancer and ChemoFx®
For hepatobiliary cancer patients receiving chemotherapy, whether as neoadjuvant chemotherapy, adjuvant chemotherapy, primary chemotherapy or combination chemotherapy, ChemoFx® can assist physicians in selecting personalized cancer treatment plans. Physicians can use ChemoFx® as a guide by testing multiple chemotherapy drugs on a patient's cancer cells before choosing one for their patient, giving patients a powerful advantage in their fight against cancer. For more information on ChemoFx® , visit http://www.chemofx.com.
Information for this webpage was gathered from the following websites:
www.cancer.gov
www.cancer.org
www.oncologychannel.com
www.chemofx.com